GALWAY, IRELAND--April 24, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Swiss pharmaceutical major Novartis International AG (NYSE:NVS) (Basel, Switzerland) has completed the planned spinoff of its Alcon eye-care business.

Within this article: Details spinoff of Alcon business, Novartis shift to higher margin medicines, job cuts and proposed "blockbuster" medicines on the way